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Thrombosis and hemostasis related disease have a heavy burden in cardiovascular disease and it is important to
have a journal where research into this can be accessed by all.At the start of our Editorship we wanted to look back and
reflect upon the journal’s successes to date, but it is also
important to look forward! The future of Thrombosis
Journal is taking shape and we would like to invite all
members of the community to contribute to the further
development of the journal to best suit the community’s
needs.
The mission statement of Thrombosis Journal was
clearly stated by the founding Editor, Dr. Raul Altman, a
highly respected and internationally known investigator in
the area of thrombosis and haemostasis. On the journal’s
website [1] he says: "Everyone should have equal access to
medical literature. Thrombosis is the most significant
cause of disability and death in the world. Thrombosis
Journal, as an open access publication, makes it possible
for anyone in the world to read high-quality research in
this important area”.
In a nutshell, this statement summarizes two important
features. Firstly, open access is being increasingly recog-
nised as a universal human right, in this particular case
the right of clinicians and scientists to unrestricted access
to new scientific data emerging from our field of interest.
Secondly, the fact that thrombosis and hemostasis related
diseases are the most important burden of cardiovascular
disease and death worldwide [2,3]! Thrombosis (arterial or
venous) is a global problem of major significance and
while there are many related biomedical journals that ei-
ther carry the topic as a main issue (e.g., Journal of
Thrombosis and Haemostasis), or devote significant space
to thrombosis and haemostasis (e.g., Blood), the “throm-
bosis” scope is so wide that there is ample need for add-
itional forums. In short, our mission statement remains
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articles published in the journal. We consider open access
a critical element in the dissemination of knowledge and
research data throughout the world. In the field of throm-
bosis (and hemostasis) many developments are relevant,
not only for the developed world, but also for those in
developing nations where access to subscription journals
may be limited, mainly because of financial constraints.
As Thrombosis Journal charges its authors to publish arti-
cles (discretionary waivers are considered on a case by
case basis for authors unable to pay), the strength of the
journal is that it can be accessed by anyone, anywhere,
without charge. This makes it a highly competitive journal
in terms of readership, throughout the world. This is also
illustrated by the “Highly accessed” papers indicated on
the Thrombosis Journal website and indeed, some of these
papers are also well cited, including a review authored
with some of my colleagues [4] that has been cited 49
times and a research article by Borna et al. [5] 53 times. An
essential element is, of course, the fact that all Thrombosis
Journal publications are immediately included in PubMed
and PubMed Central.
We acknowledge that potential authors can experience
pressure from their employers, grant providers, etc., to
publish in journals with a high impact factor. While we
recongnize that we are still small in terms of such quality
indicators, we will be working closely with the journal’s
publisher, BioMed Central, to ensure we are attracting
more publications of sufficient interest with aim of achiev-
ing an impact factor for the journal. Dr Yukio Ozaki and I
were put forward by Dr. Altman as his successors, offering
him the chance to take a small step back from his very
busy working life. We are taking over with the strong be-
lief that we will be able to further strengthen Thrombosis
Journal as an open access journal that matters!
For this reason we urge you to consider us when sub-
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interest, and review articles. Since we are an online jour-
nal there are no limitations on the numbers of figures or
other illustrations or colors, which creates more flexibil-
ity. We also encourage initiatives for special issues or
series of articles on any topic that fits the journal. More-
over, we would like to encourage a global scope, mean-
ing that we encourage colleagues from anywhere to
consider our journal for their publications. At the same
time opening up does not mean becoming less critical of
the contents of submissions. As before, we aim to accept
papers that may not have high interest levels but are sci-
entifically sound and contribute to the field of research.
In aiming for a global, open access journal for the entire
community dealing with thrombosis and hemostasis
related disorders (also including cardiovascular diseases
with a thrombotic origin, such as myocardial infarction
and stroke), we take the baton from Raul Altman. In
addition to his research, Dr Altman is also known for his
continuous efforts to provide high quality education in
thrombosis and hemostasis throughout South America.
We feel, as a final remark, that Thrombosis Journal could
also contribute to education and therefore we welcome
the introduction of a “In the clinic” series of reviews pro-
viding practical answers to situations encountered in
thrombosis and hemostasis clinics. We invite you to sub-
mit any manuscripts that would fall under this category to
the Thrombosis Journal.
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